Clinical trial
Study on Patient- and Caregiver-reported Symptoms and Outcomes With Levodopa/Carbidopa Intestinal Gel for the Treatment of Advanced Parkinson's Disease
NCT02289729 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on Patient- and Caregiver-reported Symptoms and Outcomes With Levodopa/Carbidopa Intestinal Gel for the Treatment of Advanced Parkinson's Disease
- Lead sponsor
- AbbVie
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2014
- Completion date
- November 30, 2016
- Enrollment
- 62 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease